Further, in the specific case of SCCHN, p16 may be non-optimal as a biomarker in HPV-negative disease, given that high levels of p16 often are used in screening for HPV-positive, virally dependent cancers [37-39]. The gene discussed is CDKN2A; the disease is cancer.